a nice little summary of the state of play, not sure if the testing details were announced in previous releases however. I think its the first time its been explicitly stated that the Clinical Trial in India will evaluate the COVID-19 ART using nasal samples as well as saliva samples.
Ann: Life Science Update, page-7
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
0.001(4.55%) |
Mkt cap ! $54.77M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.3¢ | 2.1¢ | $8.394K | 381.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1199212 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 642868 | 9 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |